| Issue Date | Title | Author(s) |
| 2023-07 | Barriers to palliative care in hepatocellular carcinoma: A review of the literature | Abasseri, M; Hoque, S; Kochovska, BAS; Caldwell, K; Sheahan, L; Zekry, A |
| 2016-01-01 | Concordance between missed days of hepatitis B virus anti-viral therapy and virological breakthrough | Sheppard-Law, SJ; Kermeen, M; Holdaway, S; Zekry, A; George, J; Dore, GJ; Maher, L |
| 2021-04-15 | Defining the temporal evolution of gut dysbiosis and inflammatory responses leading to hepatocellular carcinoma in Mdr2 -/- mouse model. | Behary, J; Raposo, AE; Amorim, NML; Zheng, H; Gong, L; McGovern, E; Chen, J; Liu, K; Beretov, J; Theocharous, C; Jackson, MT; Seet-Lee, J; McCaughan, GW; El-Omar, EM; Zekry, A |
| 2016-01-01 | Factors associated with adherence to hepatocellular carcinoma surveillance in patients under going hepatitis B anti-viral therapy in Australia | Sheppard-Law, SJ; Zablotska-Manos, I; Kermeen, M; Holdaway, S; Lee, A; Zekry, A; George, J; Maher, L |
| 2017-01-01 | Factors associated with HBV virological breakthrough | Sheppard-Law, S; Zablotska-Manos, I; Kermeen, M; Holdaway, S; Lee, A; Zekry, A; Dore, GJ; George, J; Maher, L |
| 2016-01-01 | Factors associated with medication adherence in patients living with cirrhosis | Polis, S; Zang, L; Mainali, B; Pons, R; Pavendranathan, G; Zekry, A; Fernandez, R |
| 2014-01-01 | Factors associated with medication adherence in patients living with cirrhosis | Polis, S; Zhang, L; Zekry, A; Fernandez, R |
| 2017-11-01 | Factors associated with medication adherence in patients living with cirrhosis (vol 25, pg 204, 2016) | Polis, S; Zhang, L; Mainali, B; Pons, R; Pavendranathan, G; Zekry, A; Fernandez, R |
| 2018-01-01 | Factors associated with non-adherence to HBV antiviral therapy | Sheppard-Law, S; Zablotska-Manos, I; Kermeen, M; Holdaway, S; Lee, A; George, J; Zekry, A; Maher, L |
| 2021-01-08 | Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma. | Behary, J; Amorim, N; Jiang, X-T; Raposo, A; Gong, L; McGovern, E; Ibrahim, R; Chu, F; Stephens, C; Jebeili, H; Fragomeli, V; Koay, YC; Jackson, M; O'Sullivan, J; Weltman, M; McCaughan, G; El-Omar, E; Zekry, A |
| 2016 | Predictors of non-adherence to HBV anti-viral therapy | Sheppard-Law, SJ; Zablotska-Manos, I; Ker-meen, M; Holdaway, S; Lee, A; Zekry, A; George, J; Maher, L |
| 2022 | Refining a Protocol for Faecal Microbiota Engraftment in Animal Models After Successful Antibiotic-Induced Gut Decontamination. | Amorim, N; McGovern, E; Raposo, A; Khatiwada, S; Shen, S; Koentgen, S; Hold, G; Behary, J; El-Omar, E; Zekry, A |
| 2018-07-01 | Utilisation of hepatocellular carcinoma screening in Australians at risk of hepatitis B virus-related carcinoma and prescribed anti-viral therapy | Sheppard-Law, S; Zablotska-Manos, I; Kermeen, M; Holdaway, S; Lee, A; George, J; Zekry, A; Maher, L |
